
Siren
Developer of a diabetic foot monitoring system used to detect and treat diabetics.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor investor investor investor investor investor investor investor investor | €0.0 | round |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor investor investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
investor investor investor investor investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
investor investor investor investor investor investor investor investor investor | €0.0 Valuation: €0.0 | round | |
investor investor | €0.0 | round | |
* | $9.5m Valuation: $59.0m | Late VC | |
Total Funding | 000k |
Related Content
Siren Care operates in the healthcare technology sector, specializing in remote patient monitoring solutions. The company’s core product is a smart sock that continuously monitors foot temperature, aimed at patients with neuropathy to prevent foot ulcers and other complications. Siren serves both patients and healthcare providers. Patients receive comfortable, temperature-monitoring socks shipped to their door every six months, along with access to web and mobile apps for real-time monitoring. Healthcare providers benefit from a remote monitoring platform that adheres to CMS guidelines, offering clinical population management tools and 24-hour support. Siren’s business model is subscription-based, generating revenue through the sale of its smart socks and associated monitoring services. The company targets a niche market of neuropathy patients and their healthcare providers, focusing on improving patient outcomes through early detection of foot injuries and inflammation.
Keywords: smart socks, neuropathy, foot ulcers, remote monitoring, healthcare technology, temperature monitoring, subscription model, patient outcomes, CMS guidelines, inflammation detection.